FMC Corporation

FMC Corporation

Develops herbicides, insecticides, and fungicides

Overview

FMC Corporation focuses on improving agriculture through science-based solutions. It develops and provides herbicides, insecticides, and fungicides, along with product formulations and technologies, to protect crops from pests and diseases while aiming to minimize environmental impact. The way FMC’s products work is by delivering active ingredients through formulations that enhance efficacy and safety, helping farmers protect yields and manage pests in a sustainable way. What sets FMC apart is its long history and explicit commitment to sustainable technologies and environmental protection, along with ongoing research to discover new active ingredients and smarter formulations. The company's overarching goal is to help farmers feed a growing global population by delivering science-driven agricultural solutions that safeguard crops and protect the planet.

Funded Recently

About FMC Corporation

Simplify's Rating
Why FMC Corporation is rated
C
Rated B on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Industrial & Manufacturing

Biotechnology

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Philadelphia, Pennsylvania

Founded

1883

Simplify Jobs

Simplify's Take

What believers are saying

  • Management reaffirmed 2026 sales guidance of $3.6 billion to $3.8 billion.
  • The $252 million India sale and $750 million notes support debt reduction.
  • Project Foundation shifts production to lower-cost sites, improving margins through 2026.

What critics are saying

  • Crop protection pricing remains weak, with Q1 2026 revenue down 4% year over year.
  • Tighter covenants and pledged collateral reduce FMC's financial flexibility immediately.
  • About $4.5 billion of debt against roughly $850 million EBITDA creates refinancing strain.

What makes FMC Corporation unique

  • FMC sells proprietary active ingredients, not commoditized seeds or generic chemicals.
  • Isoflex gained EU approval on April 6, 2026, widening European herbicide access.
  • Three newest molecules generated about $200 million in 2025, proving pipeline traction.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$750M

Above

Industry Average

Funded Over

1 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison
Coming Soon

Benefits

Professional Development Budget

Family Planning Benefits

Mental Health Support

Stock Price

Company News

Yahoo Finance
Mar 31st, 2026
FMC Corp shares jump 6.66% ahead of $0.08 dividend and Q1 earnings amid revenue decline forecast

FMC Corporation shares climbed 6.66% on Monday to close at $16.81, extending its winning streak to seven consecutive days. The rally came as investors positioned ahead of the company's dividend cutoff date and upcoming earnings release. FMC will distribute 8 cents per share to shareholders of record as of 31st March, payable on 16th April. The company is scheduled to report first-quarter results after market close on 29th April. For the first quarter, FMC expects revenues of $725 million to $775 million, excluding India operations, representing a 5% year-on-year decline. Adjusted EBITDA is forecast at $45 million to $55 million, down 54% to 62.5% from the prior year. For full-year 2026, the company targets revenues of $3.6 billion to $3.8 billion, with adjusted EBITDA of $670 million to $730 million.

Yahoo Finance
Feb 7th, 2026
FMC Corporation: Deep-value play emerges after 83% dividend cut amid agricultural headwinds

FMC Corporation, an agricultural sciences company, has emerged as a potential deep-value opportunity following an 83% dividend cut and severe sell-off driven by agricultural demand weakness and pricing pressures. Trading at $16.02 with a forward P/E of 7.18, the stock reflects significant market pessimism. Despite third-quarter 2025 revenue declining materially, adjusted earnings improved year-over-year through cost controls and favourable product mix. However, the company faces substantial balance sheet risk with approximately $4.5 billion in debt against expected EBITDA of $850 million, pushing leverage above 5×. Management is prioritising debt reduction through potential divestitures, including its India business, whilst maintaining investment in new active ingredients and biological products. The investment case depends on agricultural cycle recovery and successful deleveraging execution. Hedge fund ownership declined from 43 to 35 funds in the third quarter.

AgFunderNews
Oct 1st, 2024
Brief: Agrospheres lands additional Series B funding to 'take a giant leap forward' in bringing biopesticides to market

Funding will help further build out the Agrospheres platform, which manufactures, encapsulates and delivers biological pesticides.

Business Wire
Jul 26th, 2024
Micropep Raises $29M in Series B Funding and Unveils Krisalix, its Proprietary Discovery Platform

Micropep Technologies (Micropep), the global leader in micropeptide technology, today announced a $29 million Series B funding round along with its pr

AgroSpheres
Dec 1st, 2023
AgroSpheres

CHARLOTTESVILLE, Va. November 27, 2023 – AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection, today announced the closing of its Series B funding round with a strategic investment from FMC Corporation (NYSE: FMC), a global leader in agriculture sciences. This investment brings the total funding in AgroSpheres’ Series B round to $25 million, demonstrating the strong confidence in the company’s innovative solutions. FMC Ventures joins Lewis and Clark AgriFood, Ospraie Ag Science, BIDRA Ventures, and Cavallo Ventures to close out the round.

Recently Posted Jobs

Sign up to get curated job recommendations

FMC Corporation is Hiring for 51 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →